Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111786957 | 11178695 | 7 | F | 20140324 | 20160913 | 20150610 | 20160916 | EXP | PHHY2014CA037559 | NOVARTIS | 57.55 | YR | M | Y | 0.00000 | 20160916 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111786957 | 11178695 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO | 21008 | 30 | MG | /month | |||||||
| 111786957 | 11178695 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO | 21008 | 40 | MG | /month | |||||||
| 111786957 | 11178695 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO | 21008 | 30 | MG | /month | |||||||
| 111786957 | 11178695 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO | 21008 | 40 | MG | /month | |||||||
| 111786957 | 11178695 | 5 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, EVERY 3 WEEKS | 21008 | 40 | MG | ||||||||
| 111786957 | 11178695 | 6 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 60 MG, UNK | 21008 | 60 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111786957 | 11178695 | 1 | Carcinoid tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111786957 | 11178695 | DE |
| 111786957 | 11178695 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111786957 | 11178695 | Blood electrolytes abnormal | |
| 111786957 | 11178695 | Blood pressure diastolic decreased | |
| 111786957 | 11178695 | Blood pressure systolic increased | |
| 111786957 | 11178695 | Death | |
| 111786957 | 11178695 | Diarrhoea | |
| 111786957 | 11178695 | Discomfort | |
| 111786957 | 11178695 | Dyspepsia | |
| 111786957 | 11178695 | Heart rate increased | |
| 111786957 | 11178695 | Inappropriate schedule of drug administration | |
| 111786957 | 11178695 | Malignant neoplasm progression | |
| 111786957 | 11178695 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111786957 | 11178695 | 1 | 20021101 | 20090302 | 0 | |
| 111786957 | 11178695 | 2 | 20090401 | 20091030 | 0 | |
| 111786957 | 11178695 | 3 | 20091130 | 0 | ||
| 111786957 | 11178695 | 4 | 20141117 | 20141117 | 0 | |
| 111786957 | 11178695 | 5 | 20141208 | 0 |